131 related articles for article (PubMed ID: 12920386)
1. Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits.
Gerra G; Ceresini S; Esposito A; Zaimovic A; Moi G; Bussandri M; Raggi MA; Molina E
Int Clin Psychopharmacol; 2003 Sep; 18(5):261-9. PubMed ID: 12920386
[TBL] [Abstract][Full Text] [Related]
2. Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlates.
Gerra G; Zaimovic A; Moi G; Bussandri M; Bubici C; Mossini M; Raggi MA; Brambilla F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):129-39. PubMed ID: 14687867
[TBL] [Abstract][Full Text] [Related]
3. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
5. A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons.
Arnold-Reed DE; Hulse GK
J Opioid Manag; 2005; 1(1):17-23. PubMed ID: 17315407
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
[TBL] [Abstract][Full Text] [Related]
7. Three methods of opioid detoxification in a primary care setting. A randomized trial.
O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
[TBL] [Abstract][Full Text] [Related]
8. Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes.
Elman I; D'Ambra MN; Krause S; Breiter H; Kane M; Morris R; Tuffy L; Gastfriend DR
Drug Alcohol Depend; 2001 Jan; 61(2):163-72. PubMed ID: 11137281
[TBL] [Abstract][Full Text] [Related]
9. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
Yang G; Zhou W; Xu K
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
[TBL] [Abstract][Full Text] [Related]
10. Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial.
Favrat B; Zimmermann G; Zullino D; Krenz S; Dorogy F; Muller J; Zwahlen A; Broers B; Besson J
Drug Alcohol Depend; 2006 Feb; 81(2):109-16. PubMed ID: 16024184
[TBL] [Abstract][Full Text] [Related]
11. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Hensel M; Kox WJ
Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
[TBL] [Abstract][Full Text] [Related]
12. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F
Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610
[TBL] [Abstract][Full Text] [Related]
13. Heart rate variability and plasma catecholamines in patients during opioid detoxification.
McDonald T; Hoffman WE; Berkowitz R; Cunningham F; Cooke B
J Neurosurg Anesthesiol; 1999 Jul; 11(3):195-9. PubMed ID: 10414675
[TBL] [Abstract][Full Text] [Related]
14. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine responses to experimentally-induced emotions among abstinent opioid-dependent subjects.
Gerra G; Baldaro B; Zaimovic A; Moi G; Bussandri M; Raggi MA; Brambilla F
Drug Alcohol Depend; 2003 Jul; 71(1):25-35. PubMed ID: 12821203
[TBL] [Abstract][Full Text] [Related]
16. Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates.
Gerra G; Zaimovic A; Raggi MA; Giusti F; Delsignore R; Bertacca S; Brambilla F
Drug Alcohol Depend; 2001 Dec; 65(1):85-95. PubMed ID: 11714593
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone shortened opioid detoxification with buprenorphine.
Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
[TBL] [Abstract][Full Text] [Related]
18. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of naltrexone-accelerated detoxification in opioid dependence.
Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G
Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668
[TBL] [Abstract][Full Text] [Related]
20. Is naltrexone a cure for heroin dependence?
Hall WD; Wodak A
Med J Aust; 1999 Jul; 171(1):9-10. PubMed ID: 10451663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
